Discussion about this post

User's avatar
Neural Foundry's avatar

Compelling case for organizational maturation. Your point about corporate development's natural ownership of build-buy-partner decisions is sharp,but one counterargument: the patient capital argument assumes corporate development already has multi-year mandate protection, which isn't universal even in mature organizations. In my experiance, the risk isn't just budget vulnerability during annual cycles, its that corp dev teams are often evaluated on short-term M&A productivity metrics themselves, which creats similar pressure to show quick wins even if the function theoretically operates on longer horizons.

Expand full comment
1 more comment...

No posts

Ready for more?